Chromosome Instability in mouse Embryonic Stem Cells

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Gaztelumendi, Nerea ^a   Nogués, Carme ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; REX-1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX;

129 MOUSE; ANIMAL; CELL CULTURE; CELL LINE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; EMBRYONIC STEM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; HUMAN; KARYOTYPING; METABOLISM; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; EMBRYONIC STEM CELLS; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MICE, 129 STRAIN; MICROSCOPY, FLUORESCENCE; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 84902827870     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05324     Document Type: Article

References (40)

1. Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981). (Pubitemid 11050741)
2. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78, 7634-7638 (1981). (Pubitemid 12186197)
3. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. & Kemler, R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27-45 (1985). (Pubitemid 15029925)
4. Robertson, E. J. [Embryo-derived stem cell lines] Teratocarcinomas And Embryonic Stem Cells: A Practical Approach [Robertson, E. J. ed.] (IRL Press, Oxford; Washington, D.C., 1987).
5. Hooper, M., Hardy, K., Handyside, A., Hunter, S. & Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326, 292-295 (1987). (Pubitemid 17053752)
6. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M. & Maeda, N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 89, 4471-4475 (1992).
7. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
8. Nagy,A., Rossant, J., Nagy, R.,Abramow-Newerly, W.&Roder, J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 90, 8424-8428 (1993). (Pubitemid 23277681)
9. Liu, X. et al. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev. Dyn. 209, 85-91 (1997). (Pubitemid 27188341)
10. Longo, L., Bygrave, A., Grosveld, F. G. & Pandolfi, P. P. The chromosome makeup of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic Res. 6, 321-328 (1997). (Pubitemid 27422816)
11. Sugawara, A., Goto, K., Sotomaru, Y., Sofuni, T. & Ito, T. Current status of chromosomal abnormalities in mouse embryonic stem cell lines used in Japan. Comp. Med. 56, 31-34 (2006).
12. Rebuzzini, P. et al. Karyotype analysis of the euploid cell population of a mouse embryonic stem cell line revealed a high incidence of chromosome abnormalities that varied during culture. Cytogenet. Genome Res. 121, 18-24 (2008). (Pubitemid 351820626)
13. Kim, Y. M., Lee, J. Y., Xia, L., Mulvihill, J. J. & Li, S. Trisomy 8: a common finding in mouse embryonic stem (ES) cell lines. Mol. Cytogenet. 6, 3 (2013).
14. Lefort, N., Perrier, A. L., Laabi, Y., Varela, C. & Peschanski,M.Human embryonic stem cells and genomic instability. Regen. Med. 4, 899-909 (2009).
15. Cowan, C. A. et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353-1356 (2004). (Pubitemid 38375373)
16. Draper, J. S., Moore, H. D., Ruban, L. N., Gokhale, P. J. & Andrews, P. W. Culture and characterization of human embryonic stem cells. Stem Cells Dev. 13, 325-336 (2004). (Pubitemid 39223282)
17. Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37, 1099-1103 (2005). (Pubitemid 41486662)
18. Mikkola, M. et al. Distinct differentiation characteristics of individual human embryonic stem cell lines. BMC Dev. Biol. 6, 40 (2006).
19. Catalina, P. et al.Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol. Cancer 7, 76 (2008).
20. Lefort, N. et al. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat. Biotechnol. 26, 1364-1366 (2008).
21. Spits, C. et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat. Biotechnol. 26, 1361-1363 (2008).
22. Mitalipova, M. M. et al. Preserving the genetic integrity of human embryonic stem cells. Nat. Biotechnol. 23, 19-20 (2005). (Pubitemid 41724618)
23. Imreh, M. P. et al. In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells. J. Cell. Biochem. 99, 508-516 (2006). (Pubitemid 44435567)
24. Humpherys, D. et al. Epigenetic instability in ES cells and cloned mice. Science 293, 95-7 (2001). (Pubitemid 32625502)
25. Hanson, C. & Caisander, G. Human embryonic stem cells and chromosome stability. APMIS 113, 751-755 (2005). (Pubitemid 43934218)
26. Caisander, G. et al. Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res. 14, 131-137 (2006).
27. Peterson, S. E. et al. Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One 6, e23018 (2011).
28. Mantel, C. et al. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability. Blood 109, 4518-4527 (2007). (Pubitemid 46743423)
29. Baker, D. E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25, 207-215 (2007). (Pubitemid 46227120)
30. Holland, A. J. & Cleveland, D. W. Losing balance: the origin and impact of aneuploidy in cancer. EMBO Rep. 13, 501-514 (2012).
31. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998). (Pubitemid 29003936)
32. Guo, J. et al. Multicolor karyotype analyses of mouse embryonic stem cells. Vitr. Cell. Dev. Biol. 41, 278-283 (2005). (Pubitemid 43104613)
33. Kristensen, D. M., Kalisz, M. & Nielsen, J. H. Cytokine signalling in embryonic stem cells. APMIS 113, 756-772 (2005). (Pubitemid 43934219)
34. Narva, E. et al.High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat. Biotechnol. 28, 371-377 (2010).
35. Varela, C. et al. Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells. J. Clin. Invest. 122, 569-574 (2012).
36. Aladjem, M. I. et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8, 145-155 (1998). (Pubitemid 28091572)
37. Lin, T. et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat. Cell Biol. 7, 165-171 (2005). (Pubitemid 40268131)
38. Damelin, M., Sun, Y. E., Sodja, V. B. & Bestor, T. H. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 8, 479-484 (2005). (Pubitemid 41773451)
39. Ginis, I. et al. Differences between human and mouse embryonic stem cells. Dev. Biol. 269, 360-380 (2004). (Pubitemid 38521104)
40. Thompson, J. R. & Gudas, L. J. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene. Mol. Cell. Endocrinol. 195, 119-133 (2002). (Pubitemid 35287167)